Blood group determinates incidence for pancreatic cancer in Germany - Wikidata - awgldk - TriplyDB

Blood group determinates incidence for pancreatic cancer in Germany

Blood group determinates incidence for pancreatic cancer in Germany

http://www.wikidata.org/entity/Q36871797

about

Association of ABO Blood Group Phenotype and Allele Frequency with Chikungunya Fever Association of gene polymorphisms in ABO blood group chromosomal regions and menstrual disorders.Clinical characteristics of acute lymphoblastic leukemia in male and female patients: A retrospective analysis of 705 patients The role of ABO blood groups in Crohn's disease and in monitoring response to infliximab treatment Risk factors and therapeutic targets in pancreatic cancer.The role of the histoblood ABO group in cancer.The ABO blood group predicts survival in esophageal squamous cell carcinoma in patients who ever smoked: a retrospective study from China.Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival.Phenotypic and allelic distribution of the ABO and Rhesus (D) blood groups in the Cameroonian population.AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy.Risk factors for pancreatic cancer: underlying mechanisms and potential targets

P2860

Q35568116-87AE8954-9660-4326-A5D9-1390D46BAAF1 Q35758195-9BF0179B-261D-4EE0-A419-4F815BC63C6C Q35803881-31E6C870-7DB2-478A-870A-94DB0ECBA0B3 Q37242662-9674FD71-D249-4F3A-9C33-E1A4606569D7 Q37317310-7FD42441-4D9B-461A-9FAC-90EA10E5BA6C Q37474539-A9F26833-5138-498E-B0C9-EE649BA19E87 Q39202716-6E884192-C0AF-4DF1-BDBC-80A04FFDF473 Q40975885-149E6028-5E28-423F-B56A-896591AEB06A Q44262237-A158C5DE-2CF2-4E3F-8E2B-72B60330354D Q47366405-BBEDC988-8E59-4107-956D-2C2A58E77BE4 Q58563303-E6159007-0748-42AB-84EA-A2FF931CBD04

P2860

Blood group determinates incidence for pancreatic cancer in Germany

http://www.wikidata.org/entity/Q36871797

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Blood group determinates incidence for pancreatic cancer in Germany

@en

type

label

Blood group determinates incidence for pancreatic cancer in Germany

@en

prefLabel

Blood group determinates incidence for pancreatic cancer in Germany

@en

P1433

Q36871797-46E8A93E-C27C-42BF-9577-18792FC55E7D

P1476

Q36871797-4879A246-8259-489C-9001-38B0918F95E0

P2093

Q36871797-21962B0E-54FE-4E03-9468-732D6784E6E1

Q36871797-32F6C65D-60FB-48F5-AD4B-5051D1904E30

Q36871797-3D8D7DBE-537C-42E9-B689-0C1FD7888785

Q36871797-417F3169-FE66-401D-89BA-64849E742A35

Q36871797-509043B9-62E3-4F7F-9CE5-9EC19AA66200

Q36871797-9B63940F-DF6E-4423-B491-B21A36E7D38B

Q36871797-E540C984-1E61-4288-87CB-44CFC08C3405

Q36871797-EDA52C2F-1DE7-4AAB-91AA-B5F247553C35

P2860

Q36871797-007E217F-72D3-4AFC-A8BF-0AA54EC60194

Q36871797-00FFF480-B281-44E2-8607-5E3F7156B705

Q36871797-30293B6F-AC6C-48C0-8883-D7A160383E05

Q36871797-39AFD92E-521B-4681-A2B5-C180491BB4D0

Q36871797-48C7214F-F0B6-4B5F-9416-827068914645

Q36871797-572CCE7D-EA2C-419B-BDE6-F7BFA4691848

Q36871797-58582110-B3B8-4D33-9EFA-FF27F4D4B664

Q36871797-641F2E9A-2EDD-4865-BC8C-2CD6162C81B7

Q36871797-7E755A0C-0FC3-458D-B47B-57FDCA3D9C0E

Q36871797-7EFE2DE8-58A5-49D5-BBE9-C88BFBC61CD2

P304

Q36871797-5E51F3DF-A72C-446D-B200-619C1C4AE64B

P31

Q36871797-3F15CDCB-2720-4558-BF44-6B8A4D4D8ECE

P356

Q36871797-18892215-5C2E-4194-B60A-9DE9A692C042

P478

Q36871797-C23F7435-182E-4F56-9B2C-C6B2FD0E08AF

P577

Q36871797-F3149EB2-BA56-4FDF-978E-ADA26F0F36A6

P5875

Q36871797-17C98691-1593-4F37-9A34-CDC82C96BE9F

P698

Q36871797-7DD965DD-E632-4AE6-9F36-F11C6B249708

P921

Q36871797-7438DC91-B94D-400C-AFCC-03D2D583A830

P932

Q36871797-B6608652-885E-4407-9590-39CE2A9E2FDD

P356

FPHYS.2013.00118

P1433

Frontiers in Physiology

P1476

Blood group determinates incidence for pancreatic cancer in Germany

@en

P2093

B Dörken

http://www.w3.org/2001/XMLSchema#string

F Klein

http://www.w3.org/2001/XMLSchema#string

H Riess

http://www.w3.org/2001/XMLSchema#string

M Bahra

http://www.w3.org/2001/XMLSchema#string

M Sinn

http://www.w3.org/2001/XMLSchema#string

O Meyer

http://www.w3.org/2001/XMLSchema#string

P Neuhaus

http://www.w3.org/2001/XMLSchema#string

U Pelzer

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer

Cancer statistics, 2010

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).

Significant association between ABO blood group and pancreatic cancer.

Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region.

ABO blood group and risk of colorectal cancer.

ABO blood group and chronic pancreatitis risk in the NAPS2 cohort.

P304

118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHYS.2013.00118

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237071324

http://www.w3.org/2001/XMLSchema#string

P698

23745115

http://www.w3.org/2001/XMLSchema#string

P921

P932

3662880

http://www.w3.org/2001/XMLSchema#string